Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works against multidrug-resistant ...

Whole genome CRISPRi screening identifies druggable vulnerabilities in an isoniazid resistant strain of Mycobacterium ...

Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works against multidrug-resistant ...

A University of Otago-led study has found a highly vulnerable weakness in drug-resistant Mycobacterium tuberculosis, offering ...

The findings of these research were presented at The Union World Conference on Lung Health in Bali, Indonesia. One of them is ...

Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works against multidrug-resistant strains, potentially inspiring improved treatments and drug development ...

Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works against multidrug-resistant strains, potentially inspiring improved treatments and drug development ...

tuberculosis strain in the presence of a single 'critical concentration' of one drug. The critical concentration of an antituberculous drug represents the lowest concentration of the drug in the ...

representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected in at least 55 countries worldwide. These data substantiate the need for ...

At Durban's King Dinuzulu Hospital, a TB patient with advanced lung disease awaits surgery for massive haemoptysis - severe ...

A University of Otago-led study has found highly vulnerable weakness in drug-resistant Mycobacterium tuberculosis, offering a ...